Besifloxacin Approved for Treatment of Conjunctivitis

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

FDA Approves Besifloxacin Drops for Treatment of Bacterial Conjunctivitis

Posted By Dr. Ari Weitzner On June 1, 2009 @ 12:44 am In Conjunctivitis,Industry News | Comments Disabled

MedPage Today reported last week that the FDA had approved besifloxacin ophthalmic suspension 0.6% (Besivance) for the treatment of bacterial conjunctivitis. Besifloxacin is made by Bausch & Lomb.

The approval was based on clinical trials showing that patients using the drug had a faster rate of infection resolution than those treated with placebo. Fewer than 3% of patients in the trials reported adverse events, which included redness of the eyes, blurred vision, eye pain, irritation and itching, and headache.

Read ^[1] the full article.

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/001208-fda-approves-besifloxacin-drops-for-treatment-of-bacterial-conjunctivitis/

URLs in this post:

[1] Read: http://www.medpagetoday.com/Ophthalmology/GeneralOphthalmology/14418?userid=212514&impressionId=1243567169825&utm_source=mSpoke&utm_medium=email&utm_campaign=DailyHeadlines&utm_content=Group1

Click here to print.